Dr. Mark Holterman, a leading pediatric surgeon, and researcher detailed the voluntary options provided by the IPSAC-VN or International Pediatric Specialists Alliance for the Children of Vietnam for the medical professionals. He says that the organization seeks the support of both volunteers and donors to improve the access to surgical care in pediatrics for the people of Vietnam (Crunchbase). Dr. Mark Holterman confirms that the volunteers help the organization in surgery, patient care, lecture, training, and more to various hospitals and medical schools in Vietnam. Volunteers should have passport and visa valid for at least six months from the date of travel. The medical professionals also should submit the copy of their CV and professional license. IPSAC-VN asks the volunteers to buy their travel medical insurance. It also suggests them to arrive at least two days prior to the starting date of volunteering.
Dr. Holterman says that 21st Century Cures Act passed by the United States Congress in 2016 offers the patients to take advantage of the fast-tracking of medical devices and new drugs. The new law gives greater support to regenerative medicine apart from its $2 billion grant to combat American opioid epidemic and other diseases. Interestingly, the new act comes in the wake of changing FDA drug approval process. The law further ensures quick and efficient FDA approval steps for some stem cell treatment procedures before it made commercially available. Different industrial bodies such as the Alliance for Regenerative Medicine and the World Stem Cell Summit welcomed the legislation.
Mark Holterman is also a full-time professor of pediatrics at the University of Illinois. He started working at the University from 2011. Dr. Mark Holterman also collaborates with Children’s Hospital of Illinois and Advocate Christ Children’s Hospital as a pediatric surgeon. He is a member of American Academy of Pediatrics and American College of Surgeons. Dr. Mark Holterman researchers in novel cancer treatments, regenerative medicine, obesity, and stem cell therapies.
Dr. Holterman completed his major in biology from Yale University and later secured his medical graduation and Ph.D. from the University of Virginia (https://doctor.webmd.com/doctor/mark-holterman-md-a978422c-387f-40a8-b4b3-b5894444d1af-overview). He started his career as a Resident by attending the University of Virginia. Dr. Mark Holterman also worked with the University of Washington, Clinical Research Institute of Montreal, Rush University Medical Center, and more.
More about Dr. Mark Holterman on Ideamensch